Therapies for brain metastases are limited in their effectiveness. A new platform using cortical organoids, derived from human induced pluripotent stem cells and combined with melanoma cells, now enables reproducible modeling of the brain metastatic niche and the targeted testing of drugs.
Paper: Paper: www.sciencedirect.com/science/article/pii/S2667237525002723
